Nabbi‐Schroeter et al38 suggested that caffeine, a nonselective antagonist of adenosine receptors, may protect against neuronal degeneration and death caused by β‐amyloid by blocking A2AR and observed that the A2BR antagonist has a certain protective effect against AD. The gene discussed is ADORA2A; the disease is Alzheimer disease.